TRCT
GNPX icon

Tower Research Capital (TRC)’s Genprex GNPX Stock Holding History

Tower Research Capital (TRC)’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-149
Closed -$5.74K – 5281
2025
Q4 		$5.74K Buy
149
+144
+2,880% +$20.3K ﹤0.01% 4099
2025
Q3 		$984 Hold
5
– – ﹤0.01% 4896
2025
Q2 		$1.36K Hold
5
– – ﹤0.01% 4822
2025
Q1 		$1.39K Hold
5
– – ﹤0.01% 4719
2024
Q4 		$5.1K Sell
5
-3
-38% -$3.93K ﹤0.01% 4351
2024
Q3 		$3.35K Buy
8
+4
+100% +$4.94K ﹤0.01% 4862
2024
Q2 		$7.34K Buy
4
+1
+33% +$2.69K ﹤0.01% 4474
2024
Q1 		$8.24K Buy
+3
New +$19.7K ﹤0.01% 4057
2023
Q4 		– Hold
0
– – – 5104
2023
Q3 		– Hold
0
– -$9.71K – 6042
2023
Q2 		– Hold
0
– – – 4231
2023
Q1 		– Hold
0
– – – 4490
2022
Q4 		– Hold
0
– – – 3711
2022
Q3 		– Hold
0
– – – 3600
2022
Q2 		– Hold
0
– – – 5542
2022
Q1 		– Hold
0
– – – 3625
2021
Q4 		– Hold
0
– – – 3846
2021
Q3 		– Hold
0
– – – 3559
2021
Q2 		– Hold
0
– -$46K – 5608
2021
Q1 		– Hold
0
– – – 3193
2020
Q4 		– Sell
-1
Closed -$155K – 3719
2020
Q3 		$93K Buy
+1
New +$158K ﹤0.01% 3197
2020
Q2 		– Hold
0
– – – 4338

Other funds holding GNPX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CVM
Cheviot Value Management Beverly Hills, California $996M AUM 25.52% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Tower Research Capital (TRC)'s GNPX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Genprex (GNPX) in Q1 2026, closing a stake of 149 shares — an estimated $5.74K sold.

Tower Research Capital (TRC) first reported a position in GNPX in Q3 2020 and held it in 9 quarters. The position peaked at $93K in Q3 2020. 15 funds tracked by Wall St. Rank hold GNPX as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Genprex position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 149 Genprex shares in Q1 2026, an estimated $5.74K.
  • Tower Research Capital (TRC) first reported a position in Genprex in Q3 2020 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Genprex position peaked at $93K in Q3 2020.
  • 15 funds tracked by Wall St. Rank held Genprex as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.